Long-term results of dose-dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial ovarian, fallopian tube …

…, S Isonishi, F Takahashi, H Michimae… - The Lancet …, 2013 - thelancet.com
… 1 h. Patients given the conventional regimen also received paclitaxel, 180 mg/m 2 on day
1, given as a 3 h intravenous infusion. In the dose-dense group, paclitaxel was given as a 1 h

Left‐truncated and right‐censored field failure data: review of parametric analysis for reliability

T Emura, H Michimae - Quality and Reliability Engineering …, 2022 - Wiley Online Library
In field reliability analyses, a data collection period is given to monitor the failure events
from the field. Left‐truncation arises due to early failures occurring before the data collection …

[HTML][HTML] A randomized phase III trial of oral S-1 plus cisplatin versus docetaxel plus cisplatin in Japanese patients with advanced non-small-cell lung cancer …

…, M Fukuda, A Yokoyama, M Takeuchi, H Michimae… - Annals of …, 2015 - Elsevier
Background Platinum-based two-drug combination chemotherapy has been standard of
care for patients with advanced nonsmall-cell lung cancer (NSCLC). The primary aim was to …

PCR analysis and specific immunohistochemistry revealing a high prevalence of non‐Helicobacter pylori Helicobacters in Helicobacter pylori‐negative gastric …

M Nakamura, A Øverby, H Michimae, H Matsui… - …, 2020 - Wiley Online Library
… We did not use other PCR primers specific for H. felis and H. salomonis because we could
not get good specificity with the reference genomes mentioned above. Primer sequences and …

Applicability of the concept of “platinum sensitivity” to recurrent endometrial cancer: the SGSG-012/GOTIC-004/Intergroup study

S Nagao, S Nishio, H Michimae, H Tanabe… - Gynecologic …, 2013 - Elsevier
Objective The concept of “platinum sensitivity” has been widely applied in the management
of recurrent ovarian cancer. This study aimed to evaluate the applicability of this concept to …

Personalized dynamic prediction of death according to tumour progression and high-dimensional genetic factors: meta-analysis with a joint model

…, M Nakatochi, S Matsui, H Michimae… - … methods in medical …, 2018 - journals.sagepub.com
Developing a personalized risk prediction model of death is fundamental for improving
patient care and touches on the realm of personalized medicine. The increasing availability of …

Effect of taxane plus platinum regimens vs doxorubicin plus cisplatin as adjuvant chemotherapy for endometrial cancer at a high risk of progression: a randomized …

H Nomura, D Aoki, H Michimae, M Mizuno… - JAMA …, 2019 - jamanetwork.com
Importance The efficacy of taxane plus platinum regimens has been demonstrated for
advanced or recurrent endometrial cancer; however, it has not been assessed in postoperative …

[HTML][HTML] Likelihood inference for copula models based on left-truncated and competing risks data from field studies

H Michimae, T Emura - Mathematics, 2022 - mdpi.com
Survival and reliability analyses deal with incomplete failure time data, such as censored and
truncated data. Recently, the classical left-truncation scheme was generalized to analyze “…

[HTML][HTML] Dynamic risk prediction via a joint frailty-copula model and IPD meta-analysis: Building web applications

T Emura, H Michimae, S Matsui - Entropy, 2022 - mdpi.com
… For a patient alive at t with his/her tumor status H ( t , X ) and covariates Z , the survival
outcome I ( D > t + w ) is calibrated by S ^ ( t , t + w | H ( t , X ) , Z ) = 1 − F ^ ( t , t + w | H ( t , X ) , Z ) . …

A tadpole‐induced polyphenism in the salamander Hynobius retardatus

H Michimae, M Wakahara - Evolution, 2002 - Wiley Online Library
… retardatus in its natural habitat) from 0900 h to 1200 h daily. They were always given … ,
approximately 5–6 days) in H. retardatus larvae (Michimae and Wakahara 2001), we considered …